Search bioRxiv⌕ Search

Biology subjects

McCaughan, G.

Publications and source records attributed to McCaughan, G..

2 recordsLinked to original sources

An open multimodal spatial resource integrating same-tissue transcriptomics, proteomics, and histology

Spatial transcriptomic and proteomic technologies provide complementary insights into tissue organisation, cellular phenotype and function, yet integrating these modalities on the same tissue section remains technically challenging. Sequential workflows must preserve RNA integrity, antigenicity and tissue morphology while maintaining accurate spatial registration. At present, publicly available multimodal datasets suitable for computational method development remain limited. Here, we present a workflow for sequential 10x Genomics Xenium spatial transcriptomics, COMET cyclic immunofluorescence, and haematoxylin and eosin (H&E) histological staining on the same formalin-fixed paraffin-embedded tissue section. We demonstrate this approach across multiple biologically distinct human tissues, including tonsil, hepatocellular adenoma, and matched tumour and non-tumour hepatocellular carcinoma, illustrating the widespread applicability of the workflow beyond a single tissue type. Following image registration, Xenium-derived cell segmentations were applied to protein images to generate integrated single-cell transcriptomic and proteomic measurements for downstream analyses. To facilitate community reuse, we publicly release four representative aligned tissue cores together with transcript coordinates, multiplex protein images, H&E images, cell segmentations, and integrated single-cell datasets. We additionally introduce UnumLocalia, an open-source visualisation and data extraction tool that enables interactive exploration of aligned multimodal images, supports user-defined cell segmentation, and allows export of integrated single-cell data for downstream analyses. Together, this technical protocol, workflow, software, and openly available dataset provide a reusable resource for multimodal spatial biology, supporting advances in biological discovery, computational method development, multimodal data integration, and validation of emerging analytical approaches across complementary spatial technologies.

immunology↗

Inhibiting SOX18 with propranolol restores vascular integrity in NR2F2-driven malformations

Translating genomic discoveries into therapies for rare genetic disorders remains a significant challenge, particularly for variants of unknown significance (VUS) where molecular mechanisms are unclear. This is particularly relevant in vascular malformations, where venous differentiation remains poorly understood, and the role of transcription factors in specifying venous identity is only beginning to be elucidated. Here, we combine live-cell single-molecule imaging with genomics-based approaches to uncover a biophysical mechanism of transcription factor antagonism that underpins venous identity. We show that SOX18 and NR2F2 antagonistically co-regulate venous differentiation through dynamic feedback between their nuclear populations. This interaction is disrupted in vascular malformation syndrome caused by a de novo heterozygous NR2F2 mutation, presenting with aberrant vascular integrity and bleeding. Treatment with an FDA-approved drug--known to inhibit SOX18--led to marked clinical improvement in the proband. To dissect the molecular mechanism underlying this mutation and the drug response, we used human embryonic stem cells (hESCs) engineered to carry the probands NR2F2 variant. These cells exhibited impaired hESC to venous differentiation with no effect on artery EC differentiation. In silico modelling and live-cell molecular imaging revealed that the NR2F2 variant is hyper-mobile, fails to form homodimers, and cannot recruit SOX18, thereby disrupting a critical transcriptional antagonism that underpins venous endothelial identity. We demonstrate that targeted pharmacological inhibition of SOX18 restores this regulatory balance in hESC-derived venous endothelial cells, rescuing both gene expression and NR2F2 binding dynamics at the single-molecule level. Together, this study uncovers a biophysical mechanism of transcription factor antagonism that governs venous differentiation and offers a framework for developing targeted therapies for rare vascular malformations.

developmental biology↗